Pill Identifier App

Label Changes for:

Zytiga (abiraterone acetate) tablets

May 2014

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) 

 

 

May 2014

6 ADVERSE REACTIONS

6.2 Post Marketing Experience...addition of non-infectious pneumonitis

 

December 2012

CONTRAINDICATIONS

Pregnancy: 
  • Zytiga can cause fetal harm when administered to a pregnant woman. Zytiga is not indicated for use in women…
 
Hide
(web1)